Sex- and strain-specific induction of renal tumors by ochratoxin A in rats correlates with DNA adduction

International Journal of Cancer

Volumn 77, Issue 1, 1998, Pages 70-75

  Castegnaro, Marcel ^a   Mohr, Ulrich ^b   Pfuhl Leszkowicz, Annie ^c   Estève, Jacques ^a   Steinmann, Jurgen ^b   Tillmann, Thomas ^b   Michelon, Jocelyne ^a   Bartsch, Helmut ^d  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c TOXALIM RESEARCH CENTRE IN FOOD TOXICOLOGY   (France)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; DEBRISOQUINE; OCHRATOXIN;

ANIMAL EXPERIMENT; ARTICLE; CARCINOGENICITY; GENETIC POLYMORPHISM; HYDROXYLATION; KIDNEY TUMOR; NONHUMAN; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; URINARY TRACT CANCER;

ANIMALS; CARCINOGENS; DNA ADDUCTS; FEMALE; KIDNEY NEOPLASMS; MALE; NEOPLASMS, EXPERIMENTAL; OCHRATOXINS; RATS; RATS, INBRED LEW; SEX FACTORS; SPECIES SPECIFICITY;

EID: 0032479415     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980703)77:1<70::AID-IJC12>3.0.CO;2-D     Document Type: Article

References (24)

1. AL-DABBAGH, S.G., IDLE, J.R. and SMITH. R.L., Animal modeling of human polymorphic drug oxidation, the metabolism of debrisoquine and phenacetin in rat inbread strains. J. Pharm. Pharmacol., 33, 161-164 (1981).
2. AYESH, R., IDLE, J.R., RICHTIE, J.C., CROTHERS, M.J. and HETZEL, M.R., Metabolic oxidation phenotypes as markers for susceptibility to lung cancer. Nature (Lond.), 312, 169-170 (1984).
3. BOOBIS, A.R., SEDDON, C.E. and DAVIES, D.S., Bufuralol l'-hydrpxylase activity of the rat. Strain differences and the effects of inhibitors. Biochem. Pharmacol., 31, 152-158 (1986).
4. CAPORASO, N., HAYES, R.B., DOSBMECI, M., HOOVER, R., HAYES, R., HETZEL, M., and IDLE, J., Lung cancer risk, occupational exposure and debrisoquine metabolic phenotype. Cancer Res., 49, 3675-3679 (1989).
5. CASTEGNARO, M., BARTSCH, H., BÉRÉZIAT, J.-C., ARVELA, P., MICHELON, J. and BROUSSOLLE, L., Polymorphic ochratoxin A hydroxylation in rat strains phenotyped as poor and extensive metabolisers of debrisoquine. Xenobiotica, 19, 225-230 (1989).
6. CASTEGNARO, M., CHERNOZEMSKY, I., HIETANEN, E. and BARTSCH, H., Are mycotoxins risk factors for endemic nephropathy and associated urothelial cancers? Arch. Geschwulstforsch., 60, 295-303 (1990).
7. CEOVIC, S., HRABAR, A., FRISIC, D., STEFANOVIC, B., BRADIC, D. and CEOVIC, J., Some epidemiologic data in the Slavionski Brod area. In: A. Pulchev, I.V. Dinev, B. Milev and D. Doichinov (eds.), Endemic nephropathy, pp. 289-293. Bulgarian Academy of Science, Sofia (1972).
8. CHERNOZEMSKY, I.N., STOYANOV, I.S., PETKOVA-BOCHAROVA, T.K., NIKOLOV, I.G., DRAGANOV, I.G., STOICHEV, I., TANCHEV, Y., NAIDUNOV, D. and KALCHEVA, N.D., Geographic correlation between the occurrence of endemic nephropathy and urinary tract tumours in Vratza district. Bulgaria. Int. J. Cancer, 19, 1-11 (1977).
9. HIETANEN, E., MALAVEILLE, C., CAMUS, A.-M. BÉRÉZIAT, J.C., BRUN, G., CASTEGNARO, M., MICHELON, J., IDLE, J.R. and BARTSCH, H., Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis ruts phenotyped as poor and extensive metabolisers of debrisoquine. Drug Metab. Dispo., 14, 118-126 (1986).
10. IARC, Mycotoxins, endemic nephropathy and urinary tract tumours, M. Castegnaro, R. Plestina, G. Dirheimer. I.N. Chernozemsky and H. Bartsch (eds.), IARC Scientific Publications 115, IARC, Lyon (1991).
11. IARC, IARC Monographs on the evaluation of carcinogenic risks of chemicals to humans. Vol. 56. Some naturally occurring substances: some food items and constituents, heterocyclic aromatic amines and mycotoxins. IARC, Lyon (1993).
12. KAHN, G.C., RIBENFIELD, M., DAVIES, D.S., MURRAY, S. and BOOBIS, A.R., Sex and strain differences in hepatic debrisoquine 4-hydroxylase activity of the rat. Drug. Metab. Disp., 13, 510-515 (1985).
13. KAISARY, A., SMITH, P., JACZQ, E., BRENDON MCALLISTER, C., WILKINSON, G.R., RAY, W.A. and BRANCH, R.A., Genetic predisposition to bladder cancer; ability to hydroxylate debrisoquine and mephenytoin as risk factors. Cancer Res., 47, 5488-5493 (1987).
14. KRIEK, E., VAN SCHOOTEN, F.J., HILLEBRAND, M.J., VAN LEEUWEN, F.E., DEN ENGELSE, L., DE LOOFF, A.J. and DIJKMANS, A.P., DNA adducts as a measure of lung cancer risk in human exposed to polycyclic aromatic hydrocarbons. Environ. Health Perpect., 99, 71-75 (1993).
15. KROGH, P., Mycotoxic porcine nephropathy: a possible model for Balkan endemic nephropathy. In: A. Pulchev, I.V. Dinev, B. Milev and D. Doichinov (eds.), Endemic nephropathy, pp. 266-270. Bulgarian Academy of Science, Sofia (1972).
16. KROGH, P., Ochratoxins: occurrence, biological effects and causal role in disease. In: D. Eaker and T. Wadstrom (eds.), Natural toxins, pp. 673-680, Pergamon, Oxford (1980).
17. KROGH, P., HALD, B. and PEDERSEN, E.J., Occurrence of ochratoxin A and citrinin in cereals associated with mycotoxic porcine nephropathy. Acta pathol, microbiol. Scand., 81, 689-695 (1973).
18. LARREY, D., DISTLERATH, L.M., DANNAN, G.A., WILKINSON, G.R. and GUENGERICH, P.P., Purification and characterization of the rat liver microsomal cytochrome P-450 involved in the 4-hydroxylation of debrisoquine, a prototype for genetic variation in oxidative drug metabolism. Biochemistry, 23, 2787-2795 (1984).
19. MARKOVIC, B., Néphropathie des Balkans et carcinomes à cellules transitionnelles. J. Urol (Paris), 91, 215-220 (1985).
20. PFOHL-LESZKOWICZ, A., GROSSE, Y., CASTEGNARO, M., PETKOVA-BOCHAROVA, T., NIKOLOV, I.G., CHERNOZEMSKY, I.N., BARTSCH, H., BETBEDER, A.M., CREPPY, E.E. and DIRHEIMER, G., Ochratoxin A related DNA adducts in urinary tract tumours of Bulgarian subjects. In: D.H. Phillips, M. Castegnaro and H. Bartsch (eds.), Postlabelling methods for detection of DNA adducts, pp. 141-148. IARC Scientific Publications 124, IARC, Lyon (1993a).
21. PFOHL-LESZKOWICZ, A., GROSSE, Y., KANE, A., CREPPY, E. and DIRHEIMER, G., Differential DNA adduct formation and disappearance in three mice tissues after treatment by the mycotoxin ochratoxin A. Mutation Res., 289, 265-273 (1993b).
22. PFOHL-LESZKOWICZ, A., GROSSE, Y., CARRIÈRE, V., CUGNENC, P.-H., BERGER, A., CARNOT, F., BEAUNE, P. and DE WAZIERS, I., High level of DNA-adducts in human colon is associated with colorectal cancer, Cancer Res., 55, 5611-5615 (1995).
23. 32P-postlabelling test for structurally diverse DNA-adducts. Carcinogenesis, 7, 1543-1551 (1986).
24. RICHTIE, J.C. and IDLE, J.R., Population studies of polymorphism in drug oxidation and its relevance to carcinogenesis. In: H. Bartsch and B. Armstrong (eds.), Host factors in human carcinogenesis, pp. 381-394, IARC Scientific Publications 39, IARC, Lyon (1982).